Technical Analysis for GRPH - Graphite Bio, Inc.

Grade Last Price % Change Price Change
D 10.89 7.19% 0.73
GRPH closed up 5.94 percent on Tuesday, December 7, 2021, on 1.56 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Up
Historical GRPH trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 7.19%
1,2,3 Retracement Bearish Bearish Swing Setup 7.19%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 7.19%
MACD Bullish Signal Line Cross Bullish 7.19%
Multiple of Ten Bullish Other 7.19%
Wide Bands Range Expansion 7.19%
Wide Bands Range Expansion 13.56%
Oversold Stochastic Weakness 13.56%
NR7 Range Contraction 23.47%
Wide Bands Range Expansion 23.47%
Older End-of-Day Signals for GRPH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 1 hour ago
Rose Above Previous Day's High about 1 hour ago
1.5x Volume Pace about 1 hour ago
Up 5% about 1 hour ago
Rose Above 20 DMA about 1 hour ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Graphite Bio, Inc. Description

Graphite Bio is a clinical-stage, next-generation gene editing company harnessing high efficiency targeted gene integration to develop a new class of therapies to potentially cure a wide range of serious and life-threatening diseases. Graphite Bio is pioneering a precision gene editing approach that could enable a variety of applications to transform human health through its potential to achieve one of medicine’s most elusive goals: to precisely "find & replace" any gene in the genome. Graphite Bio’s platform allows it to precisely correct mutations, replace entire disease-causing genes with normal genes or insert new genes into predetermined, safe locations. The company was co-founded by academic pioneers in the fields of gene editing and gene therapy, including Maria Grazia Roncarolo, M.D., and Matthew Porteus, M.D., Ph.D.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Gene Therapy Genetic Engineering Bioethics

Is GRPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 34.0
52 Week Low 8.11
Average Volume 202,650
200-Day Moving Average 0.00
50-Day Moving Average 12.29
20-Day Moving Average 10.40
10-Day Moving Average 9.25
Average True Range 1.01
ADX 46.69
+DI 18.08
-DI 24.63
Chandelier Exit (Long, 3 ATRs) 10.44
Chandelier Exit (Short, 3 ATRs) 11.14
Upper Bollinger Bands 13.16
Lower Bollinger Band 7.64
Percent B (%b) 0.46
BandWidth 53.13
MACD Line -1.00
MACD Signal Line -1.10
MACD Histogram 0.0938
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.62
Resistance 3 (R3) 11.63 11.15 11.38
Resistance 2 (R2) 11.15 10.77 11.14 11.30
Resistance 1 (R1) 10.65 10.54 10.90 10.65 11.22
Pivot Point 10.17 10.17 10.30 10.17 10.17
Support 1 (S1) 9.68 9.80 9.93 9.67 9.10
Support 2 (S2) 9.20 9.57 9.19 9.02
Support 3 (S3) 8.70 9.20 8.94
Support 4 (S4) 8.70